EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022

Milla Laine iD, Jani Raitanen, Anssi Auvinen iD

European Journal of Neurology · 2026-04 · 33 (4)

DOI: 10.1111/ene.70586 ↗

At a glance

Journal article in European Journal of Neurology, published online on 2026-04-05. Written by Milla Laine and 2 co-authors. Institution: Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland. Major MEDLINE topics: Amyotrophic Lateral Sclerosis. Cited 1 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. We assessed changes in the mortality from ALS in Finland from 1987 to 2022.

Methods

Numbers of deaths caused by ALS (ICD‐10 code G12.2) and population sizes by sex, age group, and year were obtained from Statistics Finland. Crude and age‐standardized mortality rates were calculated. The annual percentage change was estimated using Poisson regression, and joinpoint regression was used to identify changes in trend during the study period.

Results

Mortality from ALS increased in Finland from 1987 to 2022. The age‐standardized ALS mortality in the entire population was 2.24/100,000 in 1987 and 4.21/100,000 in 2022. The male: female ratio in mortality was 1.18. The age‐standardized mortality increased on average by 1.7% (95% CI 1.5%–2.0%) annually. In men, the age‐standardized mortality increased on average by 1.2% (95% CI 0.9%–1.6%) annually and in women by 2.0% (95% CI 1.6%–2.3%). The largest increase occurred in the oldest age group (70+ years), with an average annual increase of 2.4% (95% CI 2.0%–2.8%). In joinpoint regression, no changes in trend were identified overall or in men, but in women, the annual percentage change (APC) was 5.5% (95% CI 3.0%–8.0%) in 1987–1997 and 1.0% (95% CI 0.5%–1.4%) during 1997–2022.

Conclusion

Similar to some other countries, mortality from ALS has increased in Finland, nearly doubling in 35 years. Further research on possible reasons is needed.

Subjects

MeSH terms (MEDLINE)

Amyotrophic Lateral SclerosisFinlandHumansFemaleMaleAgedMiddle AgedAdultAged, 80 and overAge Distribution

Author keywords

Finlandamyotrophic lateral sclerosisepidemiologymortalitymotor neuron disease

Authors and institutions

  • Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
  • Tampere University, Faculty of Social Sciences, Unit of Health Sciences, Tampere, Finland.
  • UKK Institute for Health Promotion Research, Tampere, Finland.

ORCID profiles: Milla Laine, Anssi Auvinen

Cite

APA

Laine, M., Raitanen, J., & Auvinen, A. (2026). Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022. European Journal of Neurology, 33(4). https://doi.org/10.1111/ene.70586

Vancouver

Laine M, Raitanen J, Auvinen A. Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022. European Journal of Neurology. 2026;33(4). doi:10.1111/ene.70586

BibTeX
@article{Laine2026,
  author = {Laine, Milla and Raitanen, Jani and Auvinen, Anssi},
  title = {Mortality From Amyotrophic Lateral Sclerosis in Finland 1987–2022},
  journal = {European Journal of Neurology},
  year = {2026},
  volume = {33},
  number = {4},
  doi = {10.1111/ene.70586}
}
Start for free →